arXiv:2607.00931v1 Announce Type: new Abstract: Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights. Current explainability approaches in this setting are computationally costly, lack robustness, and reduce complex drug response to univariate gene importance scores, overlooking the coordinated gene activity that drives sensitivity and resistance. In this work, we present ILLUME+, a scal
The increasing sophistication of machine learning in biology necessitates more robust and interpretable models to bridge the gap between predictive accuracy and biological insights, moving beyond simplistic feature attribution.
This work represents a significant advancement in applying explainable AI to personalized medicine, offering a path to more reliable drug discovery and patient treatment strategies by understanding complex biological interactions.
Current explainability methods for cancer drug response, often limited to univariate gene importance, are being replaced by more sophisticated, robust, and computationally efficient approaches that consider coordinated gene activity.
- · Precision oncology and pharmaceutical companies
- · Patients undergoing cancer treatment
- · AI/ML researchers in bioinformatics
- · Developers of simplistic 'black-box' AI models in healthcare
- · Traditional drug discovery pipelines reliant on univariate analysis
Improved understanding and prediction of cancer drug efficacy for individual patients.
Accelerated development of new, targeted cancer therapies and improved clinical trial design.
The integration of AI-driven, explainable biological insights becoming a standard for all drug development and personalized medicine.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG